A PTN-Rich MSC Subtype Promotes Cartilage Repair in End-Stage Knee Osteoarthritis
Mesenchymal stem cell (MSC) therapy for end-stage knee osteoarthritis (KOA) shows inconsistent efficacy, and whether MSCs retain cartilage repair capacity in the inflammatory joint remains unclear. Using single-cell RNA sequencing of human Kellgren-Lawrence grade III (G III) and IV (G IV) KOA joint tissues and exogenou...